Organoid‐based precision medicine in pancreatic cancer
United European Gastroenterology Journal · 2025-02 · 13 (1) · 21-33
DOI: 10.1002/ueg2.12701 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift United European Gastroenterology Journal, online erschienen am 14.11.2024. Verfasst von Alica K Beutel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Organoids, Precision Medicine, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, Medizinische Fakultät, Universität Ulm.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) ranks among the leading causes of cancer‐related deaths worldwide. Despite advances in precision oncology in other malignancies, treatment of PDAC still largely relies on conventional chemotherapy. Given the dismal prognosis and heterogeneity in PDAC, there is an urgent need for personalized therapeutic strategies to improve treatment response. Organoids, generated from patients' tumor tissue, have emerged as a powerful tool in cancer research. These three‐dimensional models faithfully recapitulate the morphological and genetic features of the parental tumor and retain patient‐specific heterogeneity. This review summarizes existing precision oncology approaches in PDAC, explores current applications and limitations of organoid cultures in personalized medicine, details preclinical studies correlating in vitro organoid prediction and patient treatment response, and provides an overview of ongoing organoid‐based clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
- Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany.
- Core Facility Organoids, Medical Faculty of Ulm University, Ulm, Germany.
- Division of Interdisciplinary Pancreatology, Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
ORCID-Profile: Alica K Beutel, Menar Ekizce, Thomas J Ettrich, Thomas Seufferlein, Johann Gout, Alexander Kleger
Förderung
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Medizinische Fakultät, Universität Ulm
- Clinician Scientist Program of Ulm University
- German Cancer Aid
Zitieren
APA
Beutel, A. K., Ekizce, M., Ettrich, T. J., Seufferlein, T., Lindenmayer, J., Gout, J., & Kleger, A. (2025). Organoid‐based precision medicine in pancreatic cancer. United European Gastroenterology Journal, 13(1), 21-33. https://doi.org/10.1002/ueg2.12701
Vancouver
Beutel AK, Ekizce M, Ettrich TJ, Seufferlein T, Lindenmayer J, Gout J, et al. Organoid‐based precision medicine in pancreatic cancer. United European Gastroenterology Journal. 2025;13(1):21-33. doi:10.1002/ueg2.12701
BibTeX
@article{Beutel2025,
author = {Beutel, Alica K and Ekizce, Menar and Ettrich, Thomas J and Seufferlein, Thomas and Lindenmayer, Jessica and Gout, Johann and Kleger, Alexander},
title = {Organoid‐based precision medicine in pancreatic cancer},
journal = {United European Gastroenterology Journal},
year = {2025},
volume = {13},
number = {1},
pages = {21--33},
doi = {10.1002/ueg2.12701}
}
EUVIMED